508 related articles for article (PubMed ID: 19039713)
1. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
Runge S; Dietz R; Haverkamp W
Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
[TBL] [Abstract][Full Text] [Related]
2. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
Morrow JP; Cannon CP; Reiffel JA
Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
[TBL] [Abstract][Full Text] [Related]
3. Dronedarone.
Patel C; Yan GX; Kowey PR
Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
[TBL] [Abstract][Full Text] [Related]
4. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
5. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Krishnamoorthy S; Lip GY
Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
[TBL] [Abstract][Full Text] [Related]
7. Effects of Class I drugs on atrial fibrillation.
Steinbeck G; Remp T; Hoffmann E
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S104-8. PubMed ID: 9727684
[TBL] [Abstract][Full Text] [Related]
8. New pharmacological targets and treatments for atrial fibrillation.
Carlsson L; Duker G; Jacobson I
Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
[TBL] [Abstract][Full Text] [Related]
9. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
Hirt MN; Eschenhagen T
Dtsch Med Wochenschr; 2010 May; 135(19):971-6. PubMed ID: 20446233
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic therapy in atrial fibrillation.
Ravens U
Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
[TBL] [Abstract][Full Text] [Related]
11. [Amiodarone: treatment or cause of atrial fibrillation?].
Allali G; Falconnet C
Rev Med Suisse; 2005 Nov; 1(39):2533-5. PubMed ID: 16323735
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacological therapies for atrial fibrillation.
Bagwe S; Leonardi M; Bissett J
Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation: cure or treat?
Forleo GB; Tondo C
Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
[TBL] [Abstract][Full Text] [Related]
14. Drugs for conversion of atrial fibrillation.
Dell'Orfano JT; Luck JC; Wolbrette DL; Patel H; Naccarelli GV
Am Fam Physician; 1998 Aug; 58(2):471-80. PubMed ID: 9713400
[TBL] [Abstract][Full Text] [Related]
15. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
[TBL] [Abstract][Full Text] [Related]
16. New pharmacological approaches to atrial fibrillation.
Milnes JT; Madge DJ; Ford JW
Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
Wettwer E; Christ T; Dobrev D; Ravens U
Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
[TBL] [Abstract][Full Text] [Related]
18. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
Podrid PJ
Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
[TBL] [Abstract][Full Text] [Related]
19. A review of the investigational antiarrhythmic agent dronedarone.
Tafreshi MJ; Rowles J
J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):15-26. PubMed ID: 17495254
[TBL] [Abstract][Full Text] [Related]
20. Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
